United States: DelawAre Supreme Court Reverses Chancery And Gives Collateral Estoppel Effect To California Federal Court’s Dismissal Of Derivative Claims - Pepper Hamilton LLP
In its widely followed Allergan decision, the Delaware Court of Chancery declined to apply collateral estoppel to dismiss a Delaware derivative complaint even though a California federal court dismissed (with prejudice) essentially the same complaint brought by different stockholders.
allergan
california
chancery
court
decision
delaware
estoppel
federal
hamilton llp
pepper
prejudice
reverses
states
supreme
united
Found 1 month ago on channel
Mondaq
Canada: Different But Hopefully Equal? Federal And Provincial Employment Standards To Be Considered By The Supreme Court - McCarthy Tétrault LLP
The Supreme Court of Canada has granted leave in an appeal about whether provincial or federal legislation governs workplace compensation for federal workers.
canada
compensation
court
employment
federal
legislation
llp
mccarthy tétrault
supreme
Found 1 month ago on channel
Mondaq
United States: U.S. Supreme Court Argument On "Reverse Payments" Suggests Potential For Compromise Holding Not Advocated By FTC Or Pharmaceuticals Industry - Loeb & Loeb LLP
The Supreme Court granted certiorari in Federal Trade Commission v. Watson Pharmaceuticals, Inc. to address whether reverse payment agreements common in Hatch-Waxman litigations are presumptively anticompetitive and unlawful.
agreement
arguments
commission
court
federal
ftc
hatch-waxman
litigation
llp
loeb
payments
pharmaceuticals
states
supreme
united
watson
Found 1 month ago on channel
Mondaq
United States: Murky Waters: Post-Approval Regulatory Activities And The § 271(e)(1) Safe Harbor - Fenwick & West LLP
On January 14, 2013, the U.S. Supreme Court refused to consider the U.S. Court of Appeals for the Federal Circuit's exclusion in Classen Immunotherapies, Inc. v. Biogen IDEC, 659 F.3d 1057 (Fed. Cir. 2011), of post-approval regulatory activity from the safe harbor established by 35 U.S.C. § 271(e)(1).
activity
appeals
biogen
cir
circuit
classen
court
exclusion
fed
federal
fenwick
idec
immunotherapies
llp
states
supreme
united
waters
west
Found 1 month ago on channel
Mondaq
United States: Supreme Court Hears Arguments In "FTC v. Actavis" - Banner & Witcoff
On March 25, 2013, the Supreme Court heard oral arguments in "Federal Trade Commission v. Actavis", which involves a circuit split regarding "pay for delay" settlements within the pharmaceutical industry.
actavis
arguments
commission
court
federal
ftc
settlement
states
supreme
united
witcoff
Found 1 month ago on channel
Mondaq